Original news and analysis on international IP policy
European Union institutions this week informally agreed on how to handle “orphan works” - those whose creators cannot be found. The proposed new directive is the first legislation to come out of the European Commission (EC) intellectual property rights strategy adopted in May 2011, Internal Market and Services Commissioner Michel Barnier said on 6 June.
All seems to come down to the numbers on the Anti-Counterfeiting Trade Agreement: how many protesters will turn up at the ACTA Action Day in Europe tomorrow and how many members of the European Parliament (EP) will vote for it in plenary on 3 July. Without the EP agreement, ACTA will fail, at least in Europe, observers say.
On the eve of the 9 June Europe-wide protests against the Anti-Counterfeiting Trade Agreement (ACTA), journalist Jennifer Baker of IDG met with Members of the European Parliament (MEPs) Christian Engström (Pirate Party) & Niccolo Rinaldi (ALDE) to discuss the current state of affairs with regard to the ACTA. Watch the video.
A conference entitled the "5th Product and Pipeline Enhancement for Generics" to be held in Washington, DC on 17-19 July will feature industry leaders in the generic, branded pharmaceutical and API industries. Issues covered will include current and upcoming changes in regulations and the market, innovation in drug pipeline, portfolio management and business development, intellectual property protection and biosimilars.
Intellectual property enforcement was discussed at yesterday’s session of the World Trade Organization council on IP-related issues in two different contexts, both involving the United States. Cuba complained about the US failure to comply with a 10-year-old ruling on a Cuban rum brand name, and the US added an agenda item on enforcement against counterfeit goods, both of which created some stir.
The UN International Telecommunication Union (ITU) today announced it would start publishing briefing papers on the issues surrounding the revision of the International Telecommunication Regulations (ITR) and explain the "processes as well participation rights and opportunities to comment."
Does the idea of a multifunctional, versatile position-sensitive detector for measuring characteristics of a beam of particles spark ideas for useful products of benefit to society and the economy? If so, then CERN has just the thing for you. In an attempt to boost the utility of its research, the European Organization for Nuclear Research (CERN), the Geneva-based intergovernmental laboratory, today announced a plan to offer its patented technologies for licence royalty-free in order to promote innovation.
International trade rules related to intellectual property rights enshrine the notion that there may be cases where exceptions to IP rights are needed by governments, such as sovereign decisions on a nation’s public health. Using those flexibilities could save millions of lives but may mean taking a tough stance in free trade negotiations with bigger trading partners, concluded a meeting of Asian stakeholders this week.
The Internet Corporation for Assigned Names and Numbers (ICANN), the domain name system technical oversight body, will shortly make public the list of applied for new domains.
The United States stands united in its opposition to any international proposal to regulate the internet or to expand the jurisdiction of the United Nations International Telecommunication Union (ITU) over the Web, US officials said on 31 May.
Compulsory licences can provide an efficient way to decrease prices of drugs in developing countries but the conditions of issuance of a licence influence the benefits countries can derive from them, particularly if the countries have a technology gap, according to an economic model presented this week at the World Intellectual Property Organization.
Médicins Sans Frontières (MSF, Doctors without Borders) announced today that it has named a new executive director of its Access to Medicines Campaign, a high-impact advocacy initiative on international public health issues in Geneva and elsewhere. Today was the last day for current Executive Director Tido von Schoen-Angerer, who completed two three-year terms in the role.